A detailed history of Vestal Point Capital, LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 80,000 shares of PTCT stock, worth $3.46 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
80,000
Previous 90,000 11.11%
Holding current value
$3.46 Million
Previous $2.75 Billion 7.84%
% of portfolio
0.23%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.39 - $37.66 $303,900 - $376,599
-10,000 Reduced 11.11%
80,000 $2.97 Billion
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $2.22 Million - $3.61 Million
90,000 New
90,000 $2.75 Billion

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.09B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.